Eli Lilly and Company (NYSE:LLY) was a part of 100 hedge fund portfolios at the end of Q2 2024, down from 109 in the previous ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 607.25% and ...

Initially approved to treat Type 2 diabetes, Ozempic and Mounjaro also can help people with Type 1 diabetes lose weight and ...

In a sweeping new lawsuit, over 900 people are claiming that Ozempic and other GLP-1 drugs caused them long-term ...

Businesses can take proactive steps now to best position themselves for a competitive advantage in the face of the seismic shift these medications will have on the industry.

Discover Citi's bullish outlook on Eli Lilly with a $1,060 target. Is now the time to invest? Find key insights and price ...

While Congress twiddles its thumbs, pharmaceutical giants like Lilly, Pfizer, and Nova Nordisk are revolutionizing healthcare ...

Injectable prescription drugs that reduce appetite — like Ozempic, Saxenda and Mounjaro — have skyrocketed in popularity in ...

A new study found that women using the weight loss drug tirzepatide (Mounjaro) lost more weight than men, but experienced ...

If you have watched any daytime television or YouTube videos over the past few years, you have no doubt seen advertisements for medications like Ozempic, Wegovy, and Mounjaro. The ads are ubiquitous, ...

A growing number of people with type 1 diabetes are becoming overweight or obese, in part because insulin can cause weight ...

The ubiquity of Ozempic has heightened the debate over body positivity and shaming of celebrities who use ldrugs to achieve ...